Karolinska Development AB (publ): Karolinska Development's portfolio company Svenska Vaccinfabriken presents scientific advancements at international conference
STOCKHOLM, Sweden, June 27, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company Svenska Vaccinfabriken has presented results from a preclinical study indicating
Karolinska Institutet Johan Dighed Svenska Vaccinfabriken Viktor Drvota Karolinska Development Ab Nasdaq Stockholm Karolinska Development
Source: finanznachrichten.de